| Financial Year |
March 31 2023 |
| Monetary Funds |
218,798,158.79 |
| Held-for-trading Financial Assets |
1,435,106.65 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,004,818,115.99 |
| Advances to Suppliers |
16,003,396.94 |
| Other Receivables |
18,540,627.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
73,659,649.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,494.58 |
| Total Current Assets |
1,333,271,550.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
519,129,147.92 |
| Investment Properties |
64,100,910.24 |
| Fixed Assetes |
751,388,535.61 |
| Under-construction Projects |
4,708,632.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,564,704.37 |
| R&D expenses |
-- |
| Goodwill |
7,046,243.81 |
| Long-Term Deferred and Prepaid Expenses |
7,661,854.51 |
| Deferred Income Tax Assets |
34,045,102.84 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,880,386,399.06 |
| Total Assets |
3,213,657,949.62 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,355,941.39 |
| Accounts Received In Advance |
148,564.59 |
| Employee Compensation Payable |
112,305,270.88 |
| Taxes Payable |
98,368,683.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
30,791,941.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,824,850.73 |
| Other Current Liabilities |
364,587.17 |
| Sub-Total of Current Liabilities |
256,225,475.94 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
36,769,543.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
68,855,918.33 |
| Total Liabilities |
325,081,394.27 |
| Paid-In Capital(Or Share Stock) |
751,165,080.00 |
| Capital Surplus |
1,646,662,694.51 |
| Surplus Reserve |
146,118,063.17 |
| LESS:Treasury Stock |
28,469,800.01 |
| Undistributed Profits |
406,554,278.55 |
| Minority Stockholder's Interest |
-16,330,682.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,904,907,237.44 |
| Owner's Equity（Stockholder's Equity） |
2,888,576,555.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,213,657,949.62 |
